Molecular genetic and cytogenetic diagnostic laboratory with ISO 15189 accreditation.
BioAnalytica-GenoType SA is a clinical diagnostic laboratory, offering state-of-the-art molecular genetic and cytogenetic services of outstanding quality to health professionals, biomedical researchers and top multinational pharmaceutical enterprises. The company performs clinical genetic analysis services, based on established international guidelines and also, provides genetic testing services to support clinical trials, and research in molecular oncology and in other biomedical fields. Both diagnostic and research activities of the company are designed to answer questions related to diagnosis, prognosis and therapy selection for haematological neoplasms, solid tumors and other human diseases. BioAnalytica-GenoType SA is a high complexity cancer genetics laboratory servicing mainly the hematology, pathology and oncology markets. BioAnalytica-GenoType tests help to rule out a suspected disease diagnosis, or to define it in terms of its genetic abnormalities at different levels (whole-genome, chromosome, gene, DNA, RNA, e.t.c). BioAnalytica-GenoType SA is recognized as a leader in providing quality laboratory services and has earned a solid reputation based on the knowledge, integrity and professionalism of its staff. It has been the first genetic laboratory in Greece and among few genetic labs in Europe that met the international internal and external quality standards to get ISO 15189 accreditation since 2007. Based on the experitise in molecular genetics and cytogenetics as well as on the engagement in both cancer diagnostics and research, the current target of BioAnalytica-GenoType SA is to expand abroad, mostly through strategic collaborations with companies that will augment the sales network internationally. www.genotypos.gr